Professor Carmel Hawley
Professor

Carmel Hawley

Email: 
Phone: 
+61 7 3176 2625

Background

Carmel Hawley MBBS, FRACP, M.Med.Sci, is a Senior Staff Specialist and Director of Haemodialysis Services at Princess Alexandra Hospital. In addition, she is an Associate Professor (A/P) of Medicine at the School of Medicine, University of Queensland and current (inaugural) Chair for the Australasian Kidney Trials network (AKTN) formed in 2005. Under A/P Hawley’s stewardship, AKTN’s research output is now recognised internationally for its quality and impact. This has driven major advances in the evidence base, that directly informs care and outcomes for people living with chronic kidney disease. A/P Hawley also holds a Master’s degree in Biostatistics, has expertise in trial management, methodology, design and conduct. She is currently involved in numerous industry-led and/or investigator initiated international and national clinical trials as either a Principal or Associate Investigator, providing leadership and direction to emerging early and mid-career researchers.

Availability

Professor Carmel Hawley is:
Available for supervision
Media expert

Fields of research

Clinical sciences

Qualifications

  • Bachelor of Medicine and Surgery and Medical Science, The University of Queensland
  • Masters (Coursework), Institution to be confirmed
  • Royal Australasian College of Physicians, Royal Australasian College of Physicians

Research interests

  • Chronic Kidney Disease

  • Kidney Transplant

  • Kidney Dialysis

  • Kidney Clinical Trials

Search Professor Carmel Hawley’s works on UQ eSpace

715 works between 1965 and 2025
All (715) Journal Article (484) Book Chapter (6) Conference Publication (223) Other Outputs (2)

381 - 400 of 715 works

2014

Conference Publication

Research priorities in chronic kidney disease: a priority setting partnership

Tong, A., Crowe, S., Chando, S., Cass, A., Chadban, S. J., Chapman, J. R., Gallagher, M., Gillis, J., Hawley, C., Hill, S., Howard, K., Johnson, D. W., Kerr, P., Mathew, T., Mckenzie, A., Parker, D., Polkinghorne, K., Perkovic, V., Pollock, C., Strippoli, G. F. M., Tugwell, P., Walker, R. G., Webster, A. C., Wilson, A., Wong, G. and Craig, J. C. (2014). Research priorities in chronic kidney disease: a priority setting partnership. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 25-27 August 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia.

Research priorities in chronic kidney disease: a priority setting partnership

2014

Journal Article

Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network

Morrish, A.T., Hawley, C.M., Johnson, D.W., Badve, S.V., Perkovic, V., Reidlinger, D.M. and Cass, A. (2014). Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network. Kidney International, 85 (1), 23-30. doi: 10.1038/ki.2013.391

Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network

2014

Conference Publication

Volumetric bone mineral density (vBMD) and functional bone-muscle unit assessment with peripheral quantitative computed tomography(pQCT) in patients with chronic kidney disease (CKD) state 4 and 5

Krisnasamy, R., Isbel, N. M., Johnson, D. W., Campbell, S. B., Mudge, D. W., Van Eps, C. L., Fiumara, F., Bolwell, J., Stanton, T. and Hawley, C. M. (2014). Volumetric bone mineral density (vBMD) and functional bone-muscle unit assessment with peripheral quantitative computed tomography(pQCT) in patients with chronic kidney disease (CKD) state 4 and 5. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourme, VIC Australia, 25-27 August 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12301

Volumetric bone mineral density (vBMD) and functional bone-muscle unit assessment with peripheral quantitative computed tomography(pQCT) in patients with chronic kidney disease (CKD) state 4 and 5

2014

Conference Publication

LIVE DONOR STUDY - IMPACT OF KIDNEY DONATION ON LP(a) AND OTHER LIPIDS AT ONE YEAR POST LIVE DONOR NEPHRECTOMY

Doucet, B., Kostner, K., Hawley, C. and Isbel, N. (2014). LIVE DONOR STUDY - IMPACT OF KIDNEY DONATION ON LP(a) AND OTHER LIPIDS AT ONE YEAR POST LIVE DONOR NEPHRECTOMY. WILEY-BLACKWELL.

LIVE DONOR STUDY - IMPACT OF KIDNEY DONATION ON LP(a) AND OTHER LIPIDS AT ONE YEAR POST LIVE DONOR NEPHRECTOMY

2013

Journal Article

Protein-bound uremic toxins, inflammation and oxidative stress: A cross-sectional study in stage 3-4 chronic kidney disease

Rossi, M., Campbell, K.L., Johnson, D.W., Stanton, T., Vesey, D.A., Coombes, J.S., Weston, K.S., Hawley, C.M., McWhinney, B.C., Ungerer, J.P.J. and Isbel, N. (2013). Protein-bound uremic toxins, inflammation and oxidative stress: A cross-sectional study in stage 3-4 chronic kidney disease. Archives of Medical Research, 45 (4), 309-317. doi: 10.1016/j.arcmed.2014.04.002

Protein-bound uremic toxins, inflammation and oxidative stress: A cross-sectional study in stage 3-4 chronic kidney disease

2013

Journal Article

Estimated GFR reporting influences recommendations for dialysis initiation

Brimble, K. Scott, Mehrotra, Rajnish, Tonelli, Marcello, Hawley, Carmel M., Castledine, Clare, McDonald, Stephen P., Levidiotis, Vicki, Gangji, Azim S., Treleaven, Darin J., Margetts, Peter J. and Walsh, Michael (2013). Estimated GFR reporting influences recommendations for dialysis initiation. Journal of the American Society of Nephrology, 24 (11), 1737-1742. doi: 10.1681/ASN.2013010035

Estimated GFR reporting influences recommendations for dialysis initiation

2013

Journal Article

Is Alpha-B Crystallin an Independent Marker for Prognosis in Lung Cancer?

Campbell-Lloyd, Andrew J. M., Mundy, Julie, Deva, Rajeev, Lampe, Guy, Hawley, Carmel, Boyle, Glen, Griffin, Rayleene, Thompson, Charles and Shah, Pallav (2013). Is Alpha-B Crystallin an Independent Marker for Prognosis in Lung Cancer?. Heart Lung and Circulation, 22 (9), 759-766. doi: 10.1016/j.hlc.2013.01.014

Is Alpha-B Crystallin an Independent Marker for Prognosis in Lung Cancer?

2013

Journal Article

Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes

Cho, Yeoungjee, Badve, Sunil V., Hawley, Carmel M., McDonald, Stephen P., Brown, Fiona G., Boudville, Neil, Bannister, Kym M., Clayton, Philip A. and Johnson, David W. (2013). Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes. Clinical Journal of the American Society of Nephrology, 8 (9), 1556-1563. doi: 10.2215/CJN.12361212

Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes

2013

Journal Article

Interventions for erythropoietin-resistant anaemia in dialysis patients (Review)

Badve Sunil V., Beller, Elaine M., Cass, Alan, Francis, Daniel P., Hawley, Carmel, Macdougall, Iain C., Perkovic, Vlado and Johnson, David W. (2013). Interventions for erythropoietin-resistant anaemia in dialysis patients (Review). Cochrane Database of Systematic Reviews, 2013 (8) CD006861. doi: 10.1002/14651858.CD006861.pub3

Interventions for erythropoietin-resistant anaemia in dialysis patients (Review)

2013

Journal Article

The HONEYPOT randomized controlled trial: statistical analysis plan

Pascoe, Elaine Mary, Lo, Serigne, Scaria, Anish, Badve, Sunil V., Beller, Elaine Mary, Cass, Alan, Hawley, Carmel Mary and Johnson, David W. (2013). The HONEYPOT randomized controlled trial: statistical analysis plan. Peritoneal Dialysis International, 33 (4), 426-435. doi: 10.3747/pdi.2012.00310

The HONEYPOT randomized controlled trial: statistical analysis plan

2013

Journal Article

Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: A randomized controlled trial (vol 18, pg 26, 2013)

Petchey, William G., Hickman, Ingrid J., Prins, Johannes B., Hawley, Carmel M., Johnson, David W., Isabel, Nicole M. and Duncan, Emma L. (2013). Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: A randomized controlled trial (vol 18, pg 26, 2013). Nephrology, 18 (6), 481-481. doi: 10.1111/nep.12095

Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: A randomized controlled trial (vol 18, pg 26, 2013)

2013

Journal Article

The outcomes of patients with ESRD and ANCA-associated Vasculitis in Australia and New Zealand

Tang, Wen, Bose, Bhadran, McDonald, Stephen P., Hawley, Carmel M., Badve, Sunil V., Boudville, Neil, Brown, Fiona G., Clayton, Philip A., Campbell, Scott B., Peh, Chen Au and Johnson, David W. (2013). The outcomes of patients with ESRD and ANCA-associated Vasculitis in Australia and New Zealand. Clinical Journal of the American Society of Nephrology, 8 (5), 773-780. doi: 10.2215/CJN.08770812

The outcomes of patients with ESRD and ANCA-associated Vasculitis in Australia and New Zealand

2013

Journal Article

Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease

Tang, Wen, McDonald, Stephen P., Hawley, Carmel M., Badve, Sunil V., Boudville, Neil C., Brown, Fiona G., Clayton, Philip A., Campbell, Scott B., de Zoysa, Janak R. and Johnson, David W. (2013). Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease. Kidney International, 83 (3), 503-510. doi: 10.1038/ki.2012.375

Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease

2013

Journal Article

End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases

Tang, Wen, McDonald, Stephen P., Hawley, Carmel M., Badve, Sunil V., Boudville, Neil, Brown, Fiona G., Clayton, Philip A., Campbell, Scott B., de Zoysa, Janak R. and Johnson, David W. (2013). End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases. Nephrology Dialysis Transplantation, 28 (2), 455-461. doi: 10.1093/ndt/gfs492

End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases

2013

Journal Article

Cardiac surgical outcomes in abdominal solid organ (renal and hepatic) transplant recipients: a case-matched study

Sharma, Rajiv, Hawley, Carmel, Griffin, Raylene, Mundy, Julie, Peters, Paul and Shah, Pallav (2013). Cardiac surgical outcomes in abdominal solid organ (renal and hepatic) transplant recipients: a case-matched study. Interactive Cardiovascular and Thoracic Surgery, 16 (2), 103-111. doi: 10.1093/icvts/ivs442

Cardiac surgical outcomes in abdominal solid organ (renal and hepatic) transplant recipients: a case-matched study

2013

Journal Article

Outcomes of extended-hours hemodialysis performed predominantly at home

Jun, M., Jardine, Meg J., Gray, Nicholas, Masterson, Rosemary, Kerr, Peter G., Agar, John W. M., Hawley, Carmel M., van Eps, Carolyn, Cass, Alan, Gallagher, Martin and Perkovic, Vlado (2013). Outcomes of extended-hours hemodialysis performed predominantly at home. American Journal of Kidney Diseases, 61 (2), 247-253. doi: 10.1053/j.ajkd.2012.08.032

Outcomes of extended-hours hemodialysis performed predominantly at home

2013

Journal Article

Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: a randomized controlled trial

Petchey, William G., Hickman, Ingrid J., Prins, Johannes B., Hawley, Carmel M., Johnson, David W. and Isbel, Nicole M. (2013). Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: a randomized controlled trial. Nephrology, 18 (1), 26-35. doi: 10.1111/j.1440-1797.2012.01662.x

Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: a randomized controlled trial

2013

Conference Publication

Global longitudinal strain is associated with obesity, inflammation, uremic toxins and arterial stiffness in patients with chronic kidney disease stages 3 and 4

Krishnasamy, R., Hawley, C., Campbell, K., Rossi, M., Coombes, J., Leano, R., Stanton, T. and Isbel, N. (2013). Global longitudinal strain is associated with obesity, inflammation, uremic toxins and arterial stiffness in patients with chronic kidney disease stages 3 and 4. 49th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Brisbane, QLD, Australia, 9-11 September 2013. Richmond, VIC, Australia: Wiley-Blackwell.

Global longitudinal strain is associated with obesity, inflammation, uremic toxins and arterial stiffness in patients with chronic kidney disease stages 3 and 4

2013

Book Chapter

An overview of erythropoietin therapy

Zirapury, Tasnim, van Eps, Carolyn, Hawley, Carmel M., Badve, Sunil V. and Johnson, David W. (2013). An overview of erythropoietin therapy. Erythropoietin: human production, potential uses and adverse effects. (pp. 31-53) New York, NY, United States: Nova Science Publishers.

An overview of erythropoietin therapy

2013

Book Chapter

Cardiovascular disease in the chronic kidney disease population - burden, pathophysiology and end-organ manifestations

Fahim, M. A. and Hawley, C. M. (2013). Cardiovascular disease in the chronic kidney disease population - burden, pathophysiology and end-organ manifestations. Renal failure: prevention, causes and treatment. (pp. 17-35) edited by Colin Andrew Hutchison. New York, United States: Nova Science Publishers.

Cardiovascular disease in the chronic kidney disease population - burden, pathophysiology and end-organ manifestations

Current funding

  • 2024 - 2029
    A multi-centre randomised controlled trial to treat acute T-cell mediated rejection in kidney and kidney pancreas transplant recipients (TACKLE-IT trial) (USyd administered MRFF ICTC 2023 grant)
    University of Sydney
    Open grant
  • 2024 - 2029
    A randomised trial of intensive vs less intensive corticosteroids for children with nephrotic syndrome (OPEN trial) (Administered by Flinders University)
    Flinders University
    Open grant
  • 2021 - 2026
    Centre of Research Excellence: Partnering with patients with chronic kidney disease to transform care and outcomes (CRE-PACT) (administered by University of Sydney)
    University of Sydney
    Open grant
  • 2021 - 2027
    An adaptive, randomised controlled trial to treat polyomavirus infections (BKPyV) in kidney and kidney pancreas transplant recipients (BEAT-BK) trial (MRFF RCRDUN led by USyd)
    University of Sydney
    Open grant
  • 2020 - 2025
    Serum phosphate to improve outcomes for dialysis patients: The PHOSPHATE Trial (HRC New Zealand)
    University of Otago
    Open grant
  • 2020 - 2025
    Evaluation of the efficacy and safety of health service dialysate sodium practice on clinical outcomes (NHMRC CTCS administered by USYD)
    University of Sydney
    Open grant
  • 2019 - 2025
    Better health through better trials: A national network to develop and implement innovative clinical trials methodology (NHMRC CRE administered by Monash University)
    Monash University
    Open grant

Past funding

  • 2021 - 2023
    Patient perspectives and involvement in co-design of a trial evaluating interventions to improve gut health in peritoneal dialysis - GUT PD Study (ISPD grant led by Eastern Institute of Technology)
    Eastern Institute of Technology
    Open grant
  • 2021 - 2024
    Better Evidence and Translation In Chronic Kidney Disease (BEAT-CKD) (administered by SAHMRI)
    South Australian Health and Medical Research Institute Limited
    Open grant
  • 2020 - 2024
    BEAT-Calci (Better Evidence And Translation in Calciphylaxis) (MRFF RCRDUN administered by University of Sydney)
    University of Sydney
    Open grant
  • 2020 - 2024
    Vascular Access outcome measure for function: a vaLidation study In haemoDialysis (VALID)
    Metro South Hospital and Health Service
    Open grant
  • 2019 - 2024
    NAVKIDS2 trial: a multi-centre, dynamic, waitlist randomized controlled trial of patient navigators in children with chronic kidney disease (MRFF RCRDUN administered by University of Sydney)
    University of Sydney
    Open grant
  • 2019 - 2021
    A Targeted Education ApproaCH to improve Peritoneal Dialysis outcomes - Cluster Randomised Controlled Trial (MSH Research Support Scheme Project Grant administered by MSHHS)
    Metro South Hospital and Health Service
    Open grant
  • 2018 - 2020
    IMPEDE-PKD (Implementation of Metformin therapy to Ease Decline of kidney function in PKD). A Clinical Trial Investigating Metformin to slow the progression of renal dysfunction in ADPKD
    PKD Foundation of Australia Limited
    Open grant
  • 2018 - 2024
    Better Evidence for Selecting Transplant Fluids: The BEST-Fluids Trial (MRFF LCTRC administered by University of Sydney)
    University of Sydney
    Open grant
  • 2017 - 2022
    Evaluation of the efficacy and safety of health service dialysate sodium practice on clinical outcomes (NHMRC Project Grant externally led by the University of Sydney)
    University of New South Wales
    Open grant
  • 2016 - 2021
    Mid Cut-Off Haemodialysis: a safety and efficacy study
    Baxter Healthcare Pty Ltd
    Open grant
  • 2016
    The BLOCADE Study
    Austin Medical Research Foundation
    Open grant
  • 2016 - 2019
    Pexivas - NIHR
    Cambridge University Hospitals NHS Foundation Trust
    Open grant
  • 2016
    The TECH-PD trial (pilot study)
    International Society of Peritoneal Dialysis
    Open grant
  • 2016 - 2021
    Better evidence, better care and outcomes for people with chronic kidney disease (NHMRC Program Grant administered by Flinders University)
    Flinders University
    Open grant
  • 2014 - 2019
    KHA Operations Support
    Kidney Health Australia
    Open grant
  • 2014 - 2017
    ANZSN Operations Support
    Australian and New Zealand Society of Nephrology
    Open grant
  • 2013 - 2018
    A randomised, double-blind, placebo-controlled trial to assess the effect of phosphate reduction with lanthanum carbonate on arterial compliance and vascular calcification in patients with chronic kid
    NHMRC Project Grant
    Open grant
  • 2013 - 2015
    FAVOURED Trial
    AMGEN Australia Pty. Ltd.
    Open grant
  • 2013
    IMPROVE: IMPROVE (IMpact of Phospate Reduction on Vascular Endpoints in Chronic Kidney Disease)
    PA Research Foundation
    Open grant
  • 2012 - 2013
    The utility of matrix metalloproteinase-2 (MMP-2) to predict peritoneal injury in the incident PD population
    Kidney Health Australia
    Open grant
  • 2012 - 2014
    Serial NT-proBNP Monitoring for Predicting Major Cardiovascular Events in the Dialysis Population
    NHMRC Project Grant
    Open grant
  • 2011 - 2013
    AVATAR: ACE Inhibition for the preservation of renal function and patient survival in kidney transplantation (Canadian Institutes of Health Research grant admin. by the Ottawa Hospital Research Inst.)
    Ottawa Hospital Research Institute
    Open grant
  • 2011 - 2015
    The Beta-blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study (NHMRC Project Grant administered by Uni Melbourne)
    University of Melbourne
    Open grant
  • 2011 - 2012
    The Utility of Serial NT-proBNP Monitoring for Predicting Cardiac Outcomes in the Dialysis Population
    Kidney Health Australia
    Open grant
  • 2010 - 2017
    PEXIVAS: Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (NHMRC Project Grant administered by the University of Adelaide)
    Central Adelaide Local Health Network Incorporated, trading as Royal Adelaide Hospital
    Open grant
  • 2010 - 2016
    Favoured: fish oil and aspirin in vascular access outcomes in renal disease
    Abbott Products Operations AG
    Open grant
  • 2010 - 2020
    IMPROVE: IMpact of Phosphate Reduction On Vascular Endpoints in chronic kidney disease
    Shire
    Open grant
  • 2008 - 2013
    A randomised controlled trial of exit site application of Medihoney(TM) for the prevention of catheter associated infections in peritoneal dialysis patients
    Queensland Health Smart Health Research Grant
    Open grant
  • 2008 - 2011
    A randomised, placebo-controlled trial of oxpentifylline on haemoglobin levels in patients with erythropoietin-resistant anaemia
    AMGEN Australia Pty. Ltd.
    Open grant
  • 2007 - 2010
    HERO (A randomized, placebo-controlled trial of oxpentifylline on haemoglobin levels in patients with erythropoietin-resistant anaemia)
    Janssen-Cilag Pty Limited (Janssen-Cilag Australia)
    Open grant
  • 2007 - 2014
    A trial of aspirin and fish oil for the prevention of thrombosis in dialysis access
    University of Western Australia
    Open grant
  • 2005 - 2016
    Australasian Kidney Trials Network (AKTN)
    NHMRC Enabling Grant
    Open grant
  • 2005 - 2011
    Australasian Clinical Trials Network in Nephrology (CTNN)
    Australian Kidney Foundation
    Open grant
  • 2005 - 2011
    Australialian Kidney Trials (AKT) Network
    Australian and New Zealand Society of Nephrology
    Open grant

Availability

Professor Carmel Hawley is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

Contact Professor Carmel Hawley directly for media enquiries about:

  • Chronic Kidney Disease
  • Haemodialysis
  • Kidney Clinical Trials
  • Kidney Dialysis
  • Kidney Transplant
  • Nephrology
  • Peritoneal Dialysis

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au